☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
publication
Myovant and Pfizer Publish the Results of Relugolix Combination Regimen in P-III LIBERTY Studies in NEJM
February 18, 2021
Jazz Reports Results of Xywav (calcium- magnesium- potassium- and sodium oxybates) in P-III Study for Cataplexy or EDS in Patients...
October 21, 2020
Novartis Reports Publication of P-IIIb LIBERTY study's Results of Aimovig (erenumab) in The Lancet
October 23, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
